Search Results
Results for: IMPAX LABORATORIES (Save this search)
Number of Results: 16
ANI Pharmaceuticals Closes Acquisition of Assets/Generic Products of Amneal/Impax
10 May 2018 - Minnesota, US-based biopharmaceutical company ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has closed the acquisition of a portfolio of generic products and other assets ...

US Generic Drug Specialists Amneal and Impax Close Merger
10 May 2018 - US-based drugmakers Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL) have closed their business combination in an all-stock transaction, the com...

ANI Pharmaceuticals to Acquire Assets/Generic Products of Amneal/Impax
2 May 2018 - Minnesota, US-based biopharmaceutical company ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has agreed to acquire a portfolio of generic products and other assets from New ...

ANI PHARMACEUTICALS TO ACQUIRE ASSETS/GENERIC PRODUCTS OF AMNEAL/IMPAX
Minnesota, US-based biopharmaceutical company ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has agreed to acquire a portfolio of generic products and other assets from New Jersey, US-ba...

FTC Clears US Generic Drug Specialists Amneal and Impax to Close Merger
30 April 2018 - The US Federal Trade Commission has cleared US-based drugmakers Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL) to close their planned busine...

FTC CLEARS US GENERIC DRUG SPECIALISTS AMNEAL AND IMPAK TO CLOSE MERGER
The US Federal Trade Commission has cleared US-based drugmakers Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL) to close their planned business combination i...

IMPAX LABORATORIES SELLS TAIWAN MANUFACTURING FACILITY FOR USD 18.5M
US-based specialty pharmaceutical company Impax Laboratories, Inc. (NASDAQ: IPXL) has entered into a definitive agreement to sell its manufacturing facility in ...

Impax Laboratories Sells Taiwan Manufacturing Facility for USD 18.5m
22 December 2017 - US-based specialty pharmaceutical company Impax Laboratories, Inc. (NASDAQ: IPXL) has entered into a definitive agreement to sell its manufacturin...

US Generic Drug Specialists Amneal and Impax to Merge
20 October 2017 - US-based drugmakers Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL) have entered into a definitive business combination in an all-stock tra...

You can compare news articles by clicking on the tick buttons
1   2   >